You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

MYDRIACYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mydriacyl, and when can generic versions of Mydriacyl launch?

Mydriacyl is a drug marketed by Alcon, Alcon Labs Inc, and Sandoz. and is included in three NDAs.

The generic ingredient in MYDRIACYL is tropicamide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tropicamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mydriacyl

A generic version of MYDRIACYL was approved as tropicamide by BAUSCH AND LOMB on July 27th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MYDRIACYL?
  • What are the global sales for MYDRIACYL?
  • What is Average Wholesale Price for MYDRIACYL?
Drug patent expirations by year for MYDRIACYL
Drug Prices for MYDRIACYL

See drug prices for MYDRIACYL

Recent Clinical Trials for MYDRIACYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Winston Chamberlain, MD, PhDPhase 4
Stanford UniversityPhase 4

See all MYDRIACYL clinical trials

Pharmacology for MYDRIACYL
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

US Patents and Regulatory Information for MYDRIACYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 012111-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 084305-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alcon MYDRIACYL tropicamide SOLUTION/DROPS;OPHTHALMIC 012111-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.